Ohtuvayre: The First Novel COPD Treatment Approved in Over a Decade

Ohtuvayre: The First Novel COPD Treatment Approved in Over a Decade

Fact checked by Jennifer KlumpPhoto Illustration by Michela Buttignol for Verywell Health; Verona PharmaOhtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients.Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that limits airflow from the lungs and can make breathing difficult. T…